GSK holds block window open with $750m Aspen sale
Pharmaceutical firm GlaxoSmithKline is selling a $750m stake in South African peer Aspen Pharmacare through a block trade on Tuesday night, continuing a strong run of blocks in recent weeks.
It will sell 28.2m shares, representing around 6% of Aspen. The shares closed at Z267.40 on Monday night.
The deal will leave GSK with 13% of Aspen. GSK will retain its seat on the board and commit to a six month lock-up on that stake.
Citi and UBS
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: email@example.com or find out more online here.